Alcon acquires Neurotech Pharmaceuticals
Cell therapies for eye diseases · USAacquired byAlconAlcon acquires the Rhode Island-based biotech company Neurotech Pharmaceuticals for $550m. Neurotech develops cell therapies for chronic and neurodegenerative eye diseases.
- Buyer
- Alcon
- Target
- Neurotech Pharmaceuticals
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- USA
- First reported
- 20/10/2026
- Source
- cash.ch
Deal-Radar no. 43-064 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by Alcon
So far this is the only transaction by Alcon published in the Deal-Radar. New deals are added every Monday.
Acquisitions abroad in Week 43/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 26 October 2026.